Biocartesian
ActiveConverting biology into digital molecular maps
This company has previously operated under “coordna bio”. A rename frequently marks a pivot in positioning or product — useful raw material for variant ideas.
About
Finding new cures requires seeing what and where the abnormal molecules are in a diseased tissue, but current tools see less than 1% of those molecules. Biocartesian combines microscopy and new chemistries to see 50X more, offering unprecedented insights into disease biology and new therapies.
Founders · 2
Co-founder of Biocartesian. Microscopy + molecular tools + engineering. Previously Bioscience Enterprise at Cambridge, Bioengineering PhD at UPenn.
Co-founder of Biocartesian. Genetics + epigenetics, next-gen sequencing. Previously PhD at UPenn, BD at imvaria.
Related startups
AI Hypothesis Engine for Molecular Discovery
Using the immune system to cure disease
